Researchers at the University of Pennsylvania have introduced lab-engineered small extracellular vesicles to target tumors in ...

Scientists from McGill University have discovered how certain microbes create powerful drugs such as antibiotics and cancer ...

An emerging class of anticancer drugs called EZH2 inhibitors may greatly enhance the potency of some cancer immunotherapies, according to a preclinical study led by Weill Cornell Medicine lymphoma ...

Researchers at Penn Medicine created an innovative cancer treatment using nano-sized capsules that can target and trigger cancer cell self-destruction.

CHICAGO, IL / ACCESS Newswire / January 22, 2025 / ("Cosmos Health" or the "Company'') (NASDAQ:COSM) , a diversified, ...

What are the key challenges in anticancer drug development, and how might they be addressed? The past three decades have seen spectacular advances in our understanding of the molecular and ...

A new twist on a decades-old anticancer strategy has shown powerful effects against multiple cancer types in a preclinical study. The experimental approach, which uses tiny capsules called small ...

Cosmos Health (COSM) has secured buy-out rights and exclusive licensing for two patented anticancer drugs targeting, among others, prostate, ...

Researchers from the University of Sharjah have identified a common herb, Artemisia herba-alba, as a potential natural ...

Researchers from Southwest Jiaotong University published the discovery of novel high affinity peptides against the protein of human DNA binding domain of FOXM1 (FOXM1-DBD) to be developed for the ...

Both of these innovative anticancer therapies, developed through cutting-edge oncology research, are protected by international patents and set to commence Clinical Phase I trials. The first ...